Individuals with subclinical atherosclerosis and cardiovascular (CV) events present high HMGB1 levels whereas atorvastatin decreases serum HMGB1 in hyperlipidemia [5], [6]. The gene discussed is HMGB1; the disease is atherosclerosis.